A Comparison of the Impact of Pharmacological Treatments on Cardioversion, Rate Control, and Mortality in Data-Driven Atrial Fibrillation Phenotypes in Critical Care
Critical care physicians are commonly faced with patients exhibiting atrial fibrillation (AF), a cardiac arrhythmia with multifaceted origins. Recent investigations shed light on the heterogeneity among AF patients by uncovering unique AF phenotypes, characterized by differing treatment strategies a...
Main Authors: | Alexander Lacki, Antonio Martinez-Millana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/11/3/199 |
Similar Items
-
Efficiency and safety of pharmacological cardioversion for atrial fibrillation
by: Aleksei V. Tarasov
Published: (2021-04-01) -
Electrical Cardioversion in Atrial Fibrillation: Success Rates
by: JRMC Admin, et al.
Published: (2018-09-01) -
Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
by: Maciej T. Wybraniec, et al.
Published: (2018-10-01) -
Current Status of Internal Cardioversion in Atrial Fibrillation.
by: Andreas Plewan, et al.
Published: (2002-04-01) -
Comparison of efficacy of pharmacological cardioversion
with antazoline and propafenone versus electrical
cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)